OFFICIAL PUBLICATION OF

by its subsidiary APPco

New once-daily Hep C treatment recommended for PBS

Megan Haggan 23/01/2017

liver cancer: "liver" spelled out on post-its hanging from line

The first and only one-tablet, once-a-day treatment for all genotypes of chronic hepatitis C infection has been recommended for PBS listing Gilead Sciences Australia has announced that the TGA has registered a new treatment for the treatment of chronic hepatitis C infection in adults. The PBAC has also recommended EPCLUSA (sofosbuvir/velpatasvir) for listing on the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Eli Lilly clarifies Mounjaro availability

Lilly doesn't have needle production facilities. That is not their fault, you can't expect them to build a needle factory…

Tony Chiang

Funding secured for non-8CPA programs

Well done! Good to see pharmacy profession progressions

Wilson Tan

New once-daily Hep C treatment recommended for PBS

Previous APP2017 welcomes back Malcolm Scrymgeour

Next The reason behind skyrocketing autism rates

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous APP2017 welcomes back Malcolm Scrymgeour

Next The reason behind skyrocketing autism rates

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.